STIM Stock Analysis: Buy, Sell, or Hold?
STIM - Neuronetics, Inc. Common Stock
$1.81
0.08 (4.62%)
▲
5d:
-10.4%
30d:
+42.52%
90d:
+7.74%
WAIT
LOW Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Aug 04, 2026
6d
Get Alerted When STIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: STIM is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: STIM is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: STIM is currently trading at $1.81, which is considered extended relative to its 30-day fair value range of $1.27 to $1.80.
Technical Outlook: Technically, STIM is in a uptrend. Immediate support is located at $1.56, while resistance sits at $2.33. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: STIM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.50 (+148.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STIM is in a uptrend. Immediate support is located at $1.56, while resistance sits at $2.33. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: STIM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.50 (+148.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.27 -
$1.80
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.6%)
- BULLISH: Trading 148.6% below Wall St target ($4.50)
- WARNING: Recommendation downgraded due to -10.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.27 -
$1.80
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.56
Resistance Level
$2.33
Current Trend
Uptrend
Technical data as of
Jul 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.36
Wall Street Target
$4.50
(+148.6%)
Revenue Growth (YoY)
7.8%
Profit Margin
-24.5%
Share & Embed Analysis
Last updated: July 28, 2026 1:16 AM ET
Data refreshes hourly during market hours. Next update: 2:16 AM
Data refreshes hourly during market hours. Next update: 2:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STIM showing a specific setup today?
Insider Activity (6 Months)
5
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorey Chernett
BUY
100000 shares
2026-04-20
Jorey Chernett
BUY
169472 shares
2026-03-20
Jorey Chernett
BUY
450000 shares
2026-03-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$86 | 46 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 49 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$100 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$79 | 56 HOLD |
